Cargando…
First Report of bla(IMP–4) and bla(SRT–2) Coproducing Serratia marcescens Clinical Isolate in China
Carbapenem-resistant Enterobacterales (CRE) has become a major therapeutic concern in clinical settings, and carbapenemase genes have been widely reported in various bacteria. In Serratia marcescens, class A group carbapenemases including SME and KPC were mostly identified. However, there are few re...
Autores principales: | Huang, Xiangning, Shen, Siquan, Shi, Qingyu, Ding, Li, Wu, Shi, Han, Renru, Zhou, Xun, Yu, Hua, Hu, Fupin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517538/ https://www.ncbi.nlm.nih.gov/pubmed/34659175 http://dx.doi.org/10.3389/fmicb.2021.743312 |
Ejemplares similares
-
First Report of bla(CTX–M–167), bla(SHV–1), and bla(TEM–1B) Carrying Klebsiella pneumonia Showing High-Level Resistance to Carbapenems
por: Li, Shirong, et al.
Publicado: (2022) -
Isolation of a Ceftazidime-Avibactam-Resistant bla(KPC-71)-Positive Klebsiella pneumoniae Clinical Isolate
por: Shen, Siquan, et al.
Publicado: (2022) -
First reported nosocomial outbreak of Serratia marcescens harboring bla(IMP-4) and bla(VIM-2) in a neonatal intensive care unit in Cairo, Egypt
por: Ghaith, Doaa Mohammad, et al.
Publicado: (2018) -
Occurrence of Serratia marcescens Carrying bla(IMP-26) and mcr-9 in Southern China: New Insights in the Evolution of Megaplasmid IMP-26
por: Zhong, Yuxia, et al.
Publicado: (2022) -
Characterization of the First Carbapenem-Resistant Pseudocitrobacter faecalis Harboring bla(OXA-181) in China
por: Shi, Qingyu, et al.
Publicado: (2022)